Crossmark

The effect of cessation of 2nd generation P2Y12 inhibitor therapy on platelet reactivity in patients 1 year after acute myocardial infarction

Crossref DOI link: https://doi.org/10.1007/s11239-018-1701-7

Published Online: 2018-06-19

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Witberg, Guy

Bathish, Jalal

Bental, Tamir

Leshem-Lev, Dorit

Assali, Abid

Kornowski, Ran

Lev, Eli
Funding

Funding for this research was provided by:

AstraZeneca (ESR 16-11897)
License Information

Text and Data Mining valid from 2018-06-19
More Information

Article History

First Online: 19 June 2018

Compliance with ethical standards

:

: The authors declare that they no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.